Navigation Links
Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.
Date:4/1/2015

LAVAL, Quebec, April 1, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer") by a subsidiary of Valeant Pharmaceuticals International ("VPI") to purchase all of the outstanding shares of Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) ("Salix") for a price of $173.00 per share in cash, without interest, less any applicable withholding taxes.  The Offer expired at midnight, Eastern time, on April 1, 2015.  Valeant expects to complete today the acquisition of Salix through a merger without a vote of the Salix stockholders pursuant to Section 251(h) of the Delaware General Corporation Law.

Computershare Trust Company, N.A., the depositary for the tender offer, has advised that, as of the expiration of the Offer, a total of 48,385,169 shares had been tendered into and not validly withdrawn from the Offer, representing approximately 75.25% of Salix's outstanding shares and a sufficient number of shares such that the minimum tender condition to the Offer was satisfied. Additionally, the depositary has advised that an additional 8,087,609 shares had been tendered by notice of guaranteed delivery, representing approximately 12.58% of Salix's outstanding shares. Accordingly, all shares that were validly tendered and not properly withdrawn were accepted for payment and Valeant will promptly pay for all such tendered shares in accordance with the terms of the Offer.

As a result of the merger, Salix will become a wholly owned subsidiary of VPI. In the merger, each share of Salix (other than those shares held by Valeant or Salix or any of their respective subsidiaries) will be cancelled and converted into the right to receive the same $173.00 per share in cash, without interest, less any applicable withholding taxes, that was paid in the Offer. Following completion of the merger, the common stock of Salix will no longer be listed for trading on the NASDAQ Global Select Market, which is expected to take effect later today.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics. More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward Looking Statements

This press release may contain forward-looking statements, including, but not limited to, the consummation of the acquisition of Salix.  Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in our most recent annual and quarterly reports and detailed from time to time in our other filings with the Securities and Exchange Commission and the Canadian Securities Administrators, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof.  We undertake no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes, except as required by law.

Contact Information:
Laurie W. Little
Valeant Pharmaceuticals International, Inc.
949-461-6002
laurie.little@valeant.com  

Media:
Renee E. Soto/Meghan Gavigan
Sard Verbinnen & Co.
212-687-8080
rsoto@sardverb.com / mgavigan@sardverb.com

Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO

 


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
2. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
3. Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
4. Valeant Pharmaceuticals Announces Receipt Of U.S. FDA Complete Response Letter For Efinaconazole
5. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
6. Valeant Pharmaceuticals Announces Public Offering Of Common Shares
7. Valeant Pharmaceuticals Prices Public Offering Of Common Shares
8. Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes
9. Valeant Pharmaceuticals Announces Exercise Of Over-Allotment Option
10. Valeant Pharmaceuticals Announces Closing of Public Offering of Common Shares
11. Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... August 28, 2020 , ... Cano ... medical centers in Florida and San Antonio is happy to announce that it ... centers. , In this capacity he will serve as community advisor, advertising talent, ...
(Date:8/27/2020)... , ... August 27, 2020 , ... The flu season is right round the corner ... well equipped with all the necessary measures before it begins to harbor its effects on ... and it is leaving a huge impact on our lives. Hence it has become even ...
(Date:8/26/2020)... ... August 26, 2020 , ... ScripHessco has announced ... The infographic breaks down ways that chiropractors can help heal sports injuries and ... ScripHessco “Athletes have an unusual amount of pressure and stress on their bodies, ...
Breaking Medicine Technology:
(Date:8/31/2020)... N.J. (PRWEB) , ... August 31, 2020 , ... ... leading cloud-based business management solution for chiropractors, announced today the launch of its ... healthcare professionals can start running their virtual practice in under 90 seconds. ...
(Date:8/31/2020)... ... ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent ... panic, experiencing deep anxiety, immense stress, and right now are needing serious relief from a ... on the planet are experiencing a great degree of emotional discomfort, be it fear or ...
(Date:8/29/2020)... ... August 29, 2020 , ... When professor and author ... greater ease than most people would. Rather than become melancholic, however, he put together ... on achieving one’s dreams. Randy Pausch took a negative situation and turned it into ...
(Date:8/28/2020)... ... August 28, 2020 , ... With in-person ... out to continue helping the specialty-diet community connect with great, gluten-free brands. At ... coupons, enter giveaways, chat with brands & watch over 50 educational classes... all ...
(Date:8/27/2020)... ... August 27, 2020 , ... ... Walk-in Dermatology team in its Greenvale, New York location. , Loren received ... Care Institute. She is certified in chemical peels, microdermabrasion, Hydrafacial MD, dermaplaning, facial ...
Breaking Medicine News(10 mins):